Industrial Biotechnology Commercialization Handbook PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Industrial Biotechnology Commercialization Handbook PDF full book. Access full book title Industrial Biotechnology Commercialization Handbook by Mark Warner Pe. Download full books in PDF and EPUB format.
Author: Mark Warner Pe
Publisher:
ISBN: 9781079229950
Category :
Languages : en
Pages : 106
Get Book
Book Description
How much will it cost, how long will it take and is the technology ready to commercialize? These are the three most common questions received from founders, investors and employees looking to commercialize novel biotechnologies. This handbook provides industry insight and practical explanations of the commercialization process, including common pitfalls to avoid on the way to success. Mark Warner is a registered professional chemical engineer who started his career at Monsanto Chemical, turning waste pulp and paper byproducts into foods and chemicals. After spending a decade in large engineering firms, he joined an early-stage renewable energy venture and has not looked back. Mark leveraged the initial biofuels experience to hold executive level positions with industry names such as Impossible Foods, Solazyme, Harris Group and Imperium Renewables. Warner Advisors LLC was founded in 2015 with a mission of assisting early-stage biotechnology companies in commercializing their technologies. To date, Mark has consulted for over 40 industrial biotechnology ventures and is recognized as an expert in biotechnology commercialization.
Author: Mark Warner Pe
Publisher:
ISBN: 9781079229950
Category :
Languages : en
Pages : 106
Get Book
Book Description
How much will it cost, how long will it take and is the technology ready to commercialize? These are the three most common questions received from founders, investors and employees looking to commercialize novel biotechnologies. This handbook provides industry insight and practical explanations of the commercialization process, including common pitfalls to avoid on the way to success. Mark Warner is a registered professional chemical engineer who started his career at Monsanto Chemical, turning waste pulp and paper byproducts into foods and chemicals. After spending a decade in large engineering firms, he joined an early-stage renewable energy venture and has not looked back. Mark leveraged the initial biofuels experience to hold executive level positions with industry names such as Impossible Foods, Solazyme, Harris Group and Imperium Renewables. Warner Advisors LLC was founded in 2015 with a mission of assisting early-stage biotechnology companies in commercializing their technologies. To date, Mark has consulted for over 40 industrial biotechnology ventures and is recognized as an expert in biotechnology commercialization.
Author:
Publisher:
ISBN:
Category : Biotechnology industries
Languages : en
Pages : 28
Get Book
Book Description
Author: Ron Hack
Publisher:
ISBN:
Category : Bioengineering
Languages : en
Pages : 264
Get Book
Book Description
A series of industry experts analyse various key aspects of the growth, development and current structure of the biotechnology industry and its prospects to the year 2000. .
Author: Robert A. Bohrer
Publisher:
ISBN: 9781594600876
Category : Biotechnology
Languages : en
Pages : 0
Get Book
Book Description
This book is a guide to the "big picture" of biotechnology law and business, presenting and analyzing the issues that arise throughout the life cycle of the biotechnology product. The book focuses primarily on the pharmaceutical field, from university research through the development process and into the marketplace. The aim of the book is to provide guidance to the biotechnology legal and business communities by providing a practical and integrated discussion of the many different topics that arise in developing biotechnology products. It is intended to be used by I.P. lawyers, FDA lawyers, business lawyers and biotech executives who want a concise introduction to the most fundamental issues in biotechnology law and business. "Understanding the molecular pathways in disease processes is critical to discovering new drugs. The equally important task is to understand the legal pathways that enable biotechnology commercialization. This book charts the course in a way that greatly improves the odds of success."--Drew Senyei, M.D., Managing Director, Enterprise Partners Venture Capital, La Jolla, CA "Bob Bohrer has provided a thorough and thoughtful guide to the biotech industry. His experience, which is based on years of examining the biotech sector, is shared in this book and provides a comprehensive and organized overview for the scientist, investor, service provider and anyone else associated with the biotech industry. This is a must-read for both the experienced biotech executives and those new to the industry."--Lisa A. Haile, J.D., Ph.D., Partner and Co-Chair, Life Sciences Group, DLA Piper US LLP "Professor Bohrer is well positioned to write this comprehensive volume. He was most likely the first legal academician to definitively determine what biotechnology incorporates, and has never stopped reflecting upon the scientific, legal, and social/ethical issues involved. Not only will person now interested in biotechnology benefit from this book, but future historians will thank him."--Douglas Dale Busch, Former General Counsel of The Salk Institute
Author: RxCommercial Research International Inc.
Publisher:
ISBN: 9781937633127
Category :
Languages : en
Pages :
Get Book
Book Description
Author: M O'Neill
Publisher: Elsevier
ISBN: 1908818158
Category : Science
Languages : en
Pages : 414
Get Book
Book Description
A biotech manager's handbook lays out - in a simple, straightforward manner - for the manager or would-be entrepreneur the basic principles of running a biotech company. Most managers in biotechnology companies are working in their first company or in their first managerial role. Their expertise and experience in the scientific part of the work can be taken as a given but there is a whole range of other skills to be learned and areas of expertise to come to terms with. Small companies do not have big budgets to hire people or time to become an expert in so many areas. The book starts by outlining the state of the biopharmaceutical industry and goes on to explain the importance of planning (no matter what the size of the company). Succeeding chapters deal with the basics of intellectual property, perspectives from a university technology transfer office and how to raise some initial funding from an investor and entrepreneur. No other 'how to' manual exists for this sector Written by a range of expert professionals in each area, all in one book Is the only 'bench to bedside' book covering the whole spectrum of development
Author: Michael G. Pappas
Publisher: Humana Press
ISBN: 9780896033207
Category : Science
Languages : en
Pages : 461
Get Book
Book Description
One comment often repeated to me by coworkers in the biotechnology industry deals with their frustration at not understanding how their particular roles fit into their company's overall scheme for developing, manufacturing, and marketing biomedical products. Although these workers know their fields of specialty and responsibilities very well, whether it be in product research and development, regulatory affairs, manufacturing, packaging, quality control, or marketing and sales, they for the most part lack an understanding of precisely how their own contributory pieces fit into the overall scheme of the corporate biotechnology puzzle. The Biotech Business Handbook was written to assist the biotechnologist-whether a tech nician, senior scientist, manager, marketing representative, or college student interested in entering the field-in building a practical knowledge base of the rapidly expanding and maturing biotechnology segment of the healthcare industry. Because biotechnology in the United States and abroad covers many disciplines, much of the information presented in this book deals with the biomedical diagnostic aspects of the industry. Business subjects for the most part unfamiliar to technically oriented people, such as the types of biotechnology corpo rations, their business and corporate structures, their financing, patent, and trademark mat ters, their special legal issues, and the contributions of their consultants are treated in a manner designed to make them clear and understandable.
Author: Martin Austin
Publisher: Routledge
ISBN: 1317105311
Category : Business & Economics
Languages : en
Pages : 192
Get Book
Book Description
Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries is an assessment of the turbulent state of pharmaceutical and biotechnology markets as we enter the second decade of the 21st Century. At the same time, the book offers a cautionary evaluation of the future financing of innovation in terms of what's gone wrong and how to succeed in the future. Martin Austin explores the challenge that the pharmaceutical (and related) industries face in terms of balancing short term, cost containment and expenditure control in areas such as internal research and development; whilst embracing in-licensing and the acquisition of innovative therapies to counteract their impending portfolio weaknesses in the mid to longer term. The first part of the book provides an engaging and convincing perspective on the context in which the industry currently finds itself; the second part is a pragmatic guide to commercialising your intellectual property; including how to recognise and value what you have as well as the new ways of working that you will need to adopt when negotiating, collaborating and contracting in partnership and alliance with others. Commentators have described in great detail the cocktail of commercial, clinical and social issues that threaten to overwhelm the pharmaceutical industry; Martin Austin's book offers a very distinctive perspective on these issues and their solution.
Author: Mark D. Dibner
Publisher: Grove's Dictionaries
ISBN:
Category : Medical
Languages : en
Pages : 722
Get Book
Book Description
Covers companies in these areas of interest: animal agriculture,aquaculture, bioinformatics, biomass conversion, biomaterials, biosensors/bioelectronics, bioseparations, cell culture, clinical diagnostics, commodity chemicals, cosmetics/health/beauty products, drug delivery, energy, environmental treatment/testing, equipment.
Author: Victor A. Vinci
Publisher: Springer Science & Business Media
ISBN: 1592593461
Category : Science
Languages : en
Pages : 533
Get Book
Book Description
A diverse team of researchers, technologists, and engineers describe, in simple and practical language, the major current and evolving technologies for improving the biocatalytic capabilities of mammalian, microbial, and plant cells. The authors present state-of-the-art techniques, proven methods, and strategies for industrial screening, cultivation, and scale-up of these cells, and describe their biotech and industrial uses. Special emphasis is given to the solving critical issues encountered during the discovery of new drugs, process development, and the manufacture of new and existing compounds. Other topics include recombinant protein expression, bioinformatics, high throughput screening, analytical tools in biotechnology, DNA shuffling, and genomics discovery.
